2009, ISBN: 3540921648

[EAN: 9783540921646], New book, [SC: 9.63], [PU: Springer Berlin Heidelberg Jul 2009], EPIDEMIOLOGIE; IMPFUNG; INFLUENZA - GRIPPE; ANTIGEN; DNAVACCINES; H5N1VIRUSES; NS1PROTEINS; RADIOLOG… Mehr…

[EAN: 9783540921646], New book, [SC: 9.63], [PU: Springer Berlin Heidelberg Jul 2009], EPIDEMIOLOGIE; IMPFUNG; INFLUENZA - GRIPPE; ANTIGEN; DNAVACCINES; H5N1VIRUSES; NS1PROTEINS; RADIOLOGIEINFORMATIONSSYSTEM; ATTENUATEDVACCINES; AVIANINFLUENZA; INFLUENZAVIRUS-LIKEPARTICLES; MICRONEEDLEPATCHES; PANDEMICINFLUENZA; PROTEIN; SEASONALINFLUENZA; TRANSCUTANEOUSIMMUNIZATION; VACCI, This item is printed on demand - it takes 3-4 days longer - Neuware -Recent years have seen unprecedented outbreaks of avian influenza A viruses. In particular, highly pathogenic H5N1 viruses have not only resulted in widespread outbreaks in domestic poultry, but have been transmitted to humans, resulting in numerous fatalities. The rapid expansion in their geographic distribution and the possibility that these viruses could acquire the ability to spread from person to person raises the risk that such a virus could cause a global pandemic with high morbidity and mortality. An effective influenza vaccine represents the best approach to prevent and control such an emerging pandemic. However, current influenza vaccines are directed at existing seasonal influenza viruses, which have little or no antigenic relationship to the highly pathogenic H5N1 strains. Concerns about pandemic preparedness have greatly stimulated research activities to develop eff- tive vaccines for pandemic influenza viruses, and to overcome the limitations inh- ent in current approaches to vaccine production and distribution. These limitations include the use of embryonated chicken eggs as the substrate for vaccine prod- tion, which is time-consuming and could involve potential biohazards in growth of new virus strains. Other limitations include the requirement that the current inac- vated influenza vaccines be administered using needles and syringes, requiring trained personnel, which could be a bottleneck when attempting to vaccinate large populations in mass campaigns. In addition, the current inactivated vaccines that are delivered by injection elicit limited protective immunity in the upper respiratory tract where the infection process is initiated. 532 pp. Englisch, Books<

ISBN: 9783540921646

Recent years have seen unprecedented outbreaks of avian influenza A viruses. In particular, highly pathogenic H5N1 viruses have not only resulted in widespread outbreaks in domestic poult… Mehr…

Recent years have seen unprecedented outbreaks of avian influenza A viruses. In particular, highly pathogenic H5N1 viruses have not only resulted in widespread outbreaks in domestic poultry, but have been transmitted to humans, resulting in numerous fatalities. The rapid expansion in their geographic distribution and the possibility that these viruses could acquire the ability to spread from person to person raises the risk that such a virus could cause a global pandemic with high morbidity and mortality. An effective influenza vaccine represents the best approach to prevent and control such an emerging pandemic. However, current influenza vaccines are directed at existing seasonal influenza viruses, which have little or no antigenic relationship to the highly pathogenic H5N1 strains. Concerns about pandemic preparedness have greatly stimulated research activities to develop eff- tive vaccines for pandemic influenza viruses, and to overcome the limitations inh- ent in current approaches to vaccine production and distribution. These limitations include the use of embryonated chicken eggs as the substrate for vaccine prod- tion, which is time-consuming and could involve potential biohazards in growth of new virus strains. Other limitations include the requirement that the current inac- vated influenza vaccines be administered using needles and syringes, requiring trained personnel, which could be a bottleneck when attempting to vaccinate large populations in mass campaigns. In addition, the current inactivated vaccines that are delivered by injection elicit limited protective immunity in the upper respiratory tract where the infection process is initiated., Springer<

2009, ISBN: 9783540921646

Editor: Compans, Richard W, Editor: Orenstein, Walter A. Springer, Hardcover, Auflage: 2009, 530 Seiten, Publiziert: 2009-07-28T00:00:01Z, Produktgruppe: Book, Hersteller-Nr.: 21 black & … Mehr…

Editor: Compans, Richard W, Editor: Orenstein, Walter A. Springer, Hardcover, Auflage: 2009, 530 Seiten, Publiziert: 2009-07-28T00:00:01Z, Produktgruppe: Book, Hersteller-Nr.: 21 black & white illustrations, 30 colou, 1.11 kg, Books Global Store, Special Features, Books, Public Health, General Medical Issues, Medical & Healthcare Practitioners, Health, Family & Lifestyle, Subjects, Immunology, Diseases & Disorders, Internal Medicine, Infectious & Contagious Diseases, Pathology, Other Branches of Medicine, Pharmacology, Microbiology, Biological Sciences, Science, Nature & Maths, Medical Sciences A-Z, Public Health & Preventive Medicine, Scientific, Technical & Medical, Medicine & Nursing, Clinical, Medicine & Health Sciences, University Textbooks, Format: Illustrated, Springer, 2009<

2009, ISBN: 3540921648

[EAN: 9783540921646], New book, [SC: 3.35], [PU: Springer], pp. 532 51 Illus. (30 Col.), Books

2009, ISBN: 3540921648

[EAN: 9783540921646], New book, [SC: 7.22], [PU: Springer], pp. 532 Index, Books